Biogen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€109.15
Target price
02.05.26
€181.51
Performance (%)
8.89%
Price
22.08.25
€118.85
Summary
This prediction is currently active. With a performance of 8.89%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.295% | 0.295% |
| iShares Core DAX® | -0.099% | 1.027% |
| iShares Nasdaq 100 | -1.085% | 2.134% |
| iShares Nikkei 225® | -0.835% | 8.556% |
| iShares S&P 500 | 0.099% | 2.881% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $217.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat